Dynavax Technologies | DVAX - PE Price to Earnings

Stock Price
15.49
Daily Change
-0.02 -0.13%
Monthly
0.52%
Yearly
17.71%
Q1 Forecast
15.01

Dynavax Technologies reported $13.52 in PE Price to Earnings for its fiscal quarter ending in September of 2025.





Pe Change Date
AbbVie USD 24.03 86.23 Dec/2025
Adma Biologics USD 17.25 4.43 Sep/2025
Amgen USD 9.49 3.02 Sep/2025
AstraZeneca USD 21.49 1.46 Sep/2025
Biogen USD 9.38 3.02 Sep/2025
BioMarin Pharmaceutical USD 19.45 4.32 Sep/2025
Bristol-Myers Squibb USD 9.28 1.04 Dec/2025
Dynavax Technologies USD 13.52 34.14 Sep/2025
Gilead Sciences USD 15.72 0.32 Sep/2025
Glaxosmithkline GBP 11.93 6.46 Sep/2025
Merck USD 8.84 0.26 Sep/2025
Neurocrine Biosciences USD 33.27 9.34 Sep/2025
Novartis USD 15.74 0.15 Sep/2025
Pfizer USD 9.3 1.57 Sep/2025
Regeneron Pharmaceuticals USD 18.11 2.91 Dec/2025
Roche Holding CHF 16.09 3.51 Dec/2025
Sarepta Therapeutics USD 27.27 0 Jun/2025
TG Therapeutics USD 13.08 75.69 Sep/2025
Vertex Pharmaceuticals USD 23.93 3.88 Sep/2025